Raising the bar on first-line immunotherapy in lung cancer

Lancet Oncol. 2017 Jan;18(1):2-3. doi: 10.1016/S1470-2045(16)30594-0. Epub 2016 Dec 5.

Authors

Jessica J Lin¹, Alice T Shaw²

Affiliations

¹ Department of Thoracic Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.
² Department of Thoracic Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. Electronic address: ashaw1@mgh.harvard.edu.

PMID: 27932066
DOI: 10.1016/S1470-2045(16)30594-0

No abstract available

Publication types

Comment

MeSH terms

Cancer Vaccines
Humans
Immunotherapy*
Lung Neoplasms*

Substances

Cancer Vaccines